🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomo...
Status
Recruiting
Location
Dept. of Nuclear Medicine, Peking University Third Hospital
Start Date
2024-07-16
Trial ID
NCT06791226
Treatments Being Tested
This feasibility trial studies the use of gallium-68 (68Ga)-FAPI as the ima...
Status
Withdrawn
Location
Stanford University Hospitals and Clinics
Start Date
2023-07
Trial ID
NCT04023240
Treatments Being Tested
Invasive squamous cell carcinoma (ISCC) represents 5 to 15% of breast cance...
Status
Not Yet Recruiting
Location
Lyon sud Hospital center - Hospices Civils de Lyon
Start Date
2026-03-30
Trial ID
NCT07313033
Treatments Being Tested
The goal of this study type: observational study (prospective study) is to ...
Status
Suspended
Location
First affiliated hospital of anhui university
Start Date
2022-04-28
Trial ID
NCT06355843
Treatments Being Tested
Positron Emission Tomography (PET) provides a valuable tool for the diagnos...
Status
Unknown
Location
China, Hubei Province
Start Date
2020-07-01
Trial ID
NCT04605939
The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2025-12-17
Trial ID
NCT07464132
Treatments Being Tested
This study is a Phase 2/3, prospective, multicenter, open-label, non-random...
Status
Recruiting
Location
BAMF Health
Start Date
2026-10
Trial ID
NCT07219238
Treatments Being Tested
Single center, prospective, diagnostic study. Patients with stage II-IIIB r...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-06-03
Trial ID
NCT07498933
Treatments Being Tested
68Ga-FAPI has been developed as a tumor-targeting agent as fibroblast activ...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2022-11-01
Trial ID
NCT05686876
Treatments Being Tested
FAP is overexpressed in the cancer-associated fibroblasts (CAFs) of 90% epi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-08-01
Trial ID
NCT05485792
Treatments Being Tested